Aspirin use and risk of hepatocellular carcinoma in patients with chronic hepatitis B with or without cirrhosis.

Heejoon Jang Yun Bin LeeHyemi MoonJong-Won ChungJoon Yeul NamEun-Ju Cho Jeong-Hoon LeeSu Jong YuYoon Jun KimJuneyoung LeeJung Hwan Yoon

Published in: Hepatology (Baltimore, Md.) (2022)

Aspirin use was associated with reduced risks of HCC and liver-associated mortality in adults with CHB. Cirrhosis status had a substantial effect on the association between aspirin use and HCC risk.

Keyphrases

cardiovascular events
low dose
antiplatelet therapy
coronary artery disease
hepatitis b virus
cardiovascular disease
anti inflammatory drugs
acute coronary syndrome
climate change
atrial fibrillation
liver fibrosis